Business Description
TFBS Bioscience Inc
ISIN : TW0006939002
Total Employee Number:
86Description
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.96 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -11.69 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.62 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.7 | |||||
3-Year Book Growth Rate | -2.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.16 | |||||
9-Day RSI | 57.47 | |||||
14-Day RSI | 52.37 | |||||
3-1 Month Momentum % | 4.74 | |||||
6-1 Month Momentum % | -1 | |||||
12-1 Month Momentum % | -7.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 2.54 | |||||
Cash Ratio | 2.2 | |||||
Days Inventory | 27.45 | |||||
Days Sales Outstanding | 59.47 | |||||
Days Payable | 21.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -7.55 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.06 | |||||
Operating Margin % | -40.39 | |||||
Net Margin % | -38.58 | |||||
EBITDA Margin % | -9.97 | |||||
FCF Margin % | -121.75 | |||||
OCF Margin % | -5.04 | |||||
ROE % | -6.22 | |||||
ROA % | -4.99 | |||||
ROIC % | -7.79 | |||||
3-Year ROIIC % | -13.9 | |||||
ROC (Joel Greenblatt) % | -8.86 | |||||
ROCE % | -5.58 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.73 | |||||
PB Ratio | 0.62 | |||||
Price-to-Tangible-Book | 0.63 | |||||
EV-to-EBIT | -7.16 | |||||
EV-to-EBITDA | -26.45 | |||||
EV-to-Revenue | 2.64 | |||||
EV-to-FCF | -2.17 | |||||
Price-to-GF-Value | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 3.16 | |||||
| Price-to-Net-Cash | 4.94 | |||||
Earnings Yield (Greenblatt) % | -13.97 | |||||
FCF Yield % | -32.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TFBS Bioscience Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 193.142 | ||
| EPS (TTM) (NT$) | -2.13 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.25 | ||
| 3-Year Sortino Ratio | -1.45 | ||
| Volatility % | 37.69 | ||
| 14-Day RSI | 52.37 | ||
| 14-Day ATR (NT$) | 0.437702 | ||
| 20-Day SMA (NT$) | 20.1175 | ||
| 12-1 Month Momentum % | -7.23 | ||
| 52-Week Range (NT$) | 18.5 - 29.25 | ||
| Shares Outstanding (Mil) | 35.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TFBS Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TFBS Bioscience Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.049819 Cash Dividend | 2024-08-09 | 38.15 (+1.19%) | ||
| 1.04:1 Stock Split | 2023-09-27 | 53.56 (+0.36%) |
Show
Entries
TFBS Bioscience Inc Frequently Asked Questions
What is TFBS Bioscience Inc(ROCO:6939)'s stock price today?
The current price of ROCO:6939 is NT$20.60. The 52 week high of ROCO:6939 is NT$29.25 and 52 week low is NT$18.50.
When is next earnings date of TFBS Bioscience Inc(ROCO:6939)?
The next earnings date of TFBS Bioscience Inc(ROCO:6939) is .
Does TFBS Bioscience Inc(ROCO:6939) pay dividends? If so, how much?
TFBS Bioscience Inc(ROCO:6939) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on TFBS Bioscience Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers